Your browser doesn't support javascript.
loading
Five-year overall survival with ipilimumab and stereotactic ablative radiotherapy for metastatic disease.
He, Kewen; Hong, David S; Tang, Chad; Sezen, Duygu; Cox, Livia; Maleki, Aurian; Bertolet, Genevieve; Nguyen, Quynh-Nhu; Comeaux, Nathan I; Schuda, Lily; Chen, Dawei; Welsh, James W.
Afiliação
  • He K; Department of Radiation Oncology, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital and Institute, Jinan, Shandong, China; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic ad
  • Hong DS; Departments of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Tang C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Sezen D; Department of Radiation Oncology, Koç University School of Medicine, Istanbul, Turkey.
  • Cox L; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Maleki A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States; Department of Chemistry, Rice University, Houston, TX, United States.
  • Bertolet G; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Nguyen QN; Department of Radiation Oncology, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital and Institute, Jinan, Shandong, China.
  • Comeaux NI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Schuda L; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Chen D; Department of Radiation Oncology, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital and Institute, Jinan, Shandong, China.
  • Welsh JW; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address: jwelsh@mdanderson.org.
Radiother Oncol ; 183: 109618, 2023 06.
Article em En | MEDLINE | ID: mdl-36921766
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Radiocirurgia / Segunda Neoplasia Primária / Neoplasias Hepáticas / Neoplasias Pulmonares Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Radiother Oncol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Radiocirurgia / Segunda Neoplasia Primária / Neoplasias Hepáticas / Neoplasias Pulmonares Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Radiother Oncol Ano de publicação: 2023 Tipo de documento: Article